当前位置:首页 - 行情中心 - 誉衡药业(002437) - 财务分析

誉衡药业

(002437)

  

流通市值:71.69亿  总市值:76.81亿
流通股本:20.96亿   总股本:22.46亿

誉衡药业(002437)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2025年半年度实现净利润1.37亿元,每股收益0.06元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2025年半年度最新股东权益206747.46万元,未分配利润-54632.56万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2025年半年度最新总资产289960.42万元,负债83212.96万元。

利润表
报告期2025-06-302025-03-312024-12-312024-09-30
营业总收入1,099,501,266.79551,255,672.122,440,732,030.171,857,506,712.57
营业总成本977,868,310.54493,551,043.762,218,794,751.251,686,482,833.11
其他经营收益
营业利润151,873,392.5769,069,634.07284,852,984.63222,300,997.03
利润总额152,089,011.4968,950,223.62283,692,120.46222,057,887
净利润137,424,012.9861,931,584.62242,540,034.93191,786,315.95
每股收益
其他综合收益-159,250.63-40,526.17476,998.7-388,301
综合收益总额137,264,762.3561,891,058.45243,017,033.63191,398,014.95
资产负债表
报告期2025-06-302025-03-312024-12-312024-09-30
流动资产:
流动资产合计988,789,329.67946,591,300.71877,194,205.18870,427,011.96
非流动资产:
非流动资产合计1,910,814,912.151,932,059,699.731,947,918,407.461,956,651,982.42
资产总计2,899,604,241.822,878,651,000.442,825,112,612.642,827,078,994.38
流动负债:
流动负债合计803,842,424.56891,911,303.84823,033,579.93871,852,980.11
非流动负债:
非流动负债合计28,287,214.9428,446,043.5229,226,752.7740,688,194.57
负债合计832,129,639.5920,357,347.36852,260,332.7912,541,174.68
所有者权益(或股东权益):
归属于母公司股东权益合计2,047,939,272.391,934,459,343.331,950,697,287.551,893,916,132.24
股东权益合计2,067,474,602.321,958,293,653.081,972,852,279.941,914,537,819.7
负债和股东权益合计2,899,604,241.822,878,651,000.442,825,112,612.642,827,078,994.38
现金流量表
报告期2025-06-302025-03-312024-12-312024-09-30
经营活动产生的现金流量:
经营活动现金流入小计1,261,295,248.11657,540,118.812,903,133,022.932,184,252,323.73
经营活动现金流出小计1,106,080,469.58551,065,624.662,492,197,219.821,883,749,821.11
经营活动产生的现金流量净额155,214,778.53106,474,494.15410,935,803.11300,502,502.62
投资活动产生的现金流量:
投资活动现金流入小计708,336,463.16263,561,086.0436,696,852.831,412,568.97
投资活动现金流出小计1,023,318,605.54376,511,825.9695,560,805.1436,264,769.45
投资活动产生的现金流量净额-314,982,142.38-112,950,739.92-58,863,952.34-4,852,200.48
筹资活动产生的现金流量:
筹资活动现金流入小计70,000,00070,000,000218,213,750218,213,750
筹资活动现金流出小计88,725,853.2682,605,612.77801,456,448.33755,655,263.66
筹资活动产生的现金流量净额-18,725,853.26-12,605,612.77-583,242,698.33-537,441,513.66
汇率变动对现金及现金等价物的影响-266,848.95-90,972.85939,419.49-674,429.25
现金及现金等价物净增加额-178,760,066.06-19,172,831.39-230,231,428.07-242,465,640.77
期末现金及现金等价物余额302,012,624.39461,608,103.49480,772,690.45468,538,477.75
补充资料:
现金及现金等价物的净增加额-178,760,066.06--230,231,428.07-
TOP↑